Rösner, T., Kretschmer, A., Lohse, S., Meyer, S., Jansen, J. H. M., Möginger, U., et al. (2016). Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor. European Journal of Cancer, 69: 440, S144.